FERLA, R. Et Al. 2015. Prevalence of Anti-Adeno-Associated Virus Serotype 8 Neutralizing Antibodies and Arylsulfatase B Cross-Reactive Immunologic Material in Mucopolysaccharidosis VI Patient Candidates for a Gene Therapy Trial. HUMAN GENE THERAPY , vol.26, no.3 , 145-152.

FERLA, R., CLAUDIANI, P., SAVARESE, M., KOZARSKY, K., PARINI, R., SCARPA, M., ... DONATI, M. A.(2015). Prevalence of Anti-Adeno-Associated Virus Serotype 8 Neutralizing Antibodies and Arylsulfatase B Cross-Reactive Immunologic Material in Mucopolysaccharidosis VI Patient Candidates for a Gene Therapy Trial. HUMAN GENE THERAPY , vol.26, no.3, 145-152.

FERLA, Rita Et Al. "Prevalence of Anti-Adeno-Associated Virus Serotype 8 Neutralizing Antibodies and Arylsulfatase B Cross-Reactive Immunologic Material in Mucopolysaccharidosis VI Patient Candidates for a Gene Therapy Trial," HUMAN GENE THERAPY , vol.26, no.3, 145-152, 2015

FERLA, Rita Et Al. "Prevalence of Anti-Adeno-Associated Virus Serotype 8 Neutralizing Antibodies and Arylsulfatase B Cross-Reactive Immunologic Material in Mucopolysaccharidosis VI Patient Candidates for a Gene Therapy Trial." HUMAN GENE THERAPY , vol.26, no.3, pp.145-152, 2015

FERLA, R. Et Al. (2015) . "Prevalence of Anti-Adeno-Associated Virus Serotype 8 Neutralizing Antibodies and Arylsulfatase B Cross-Reactive Immunologic Material in Mucopolysaccharidosis VI Patient Candidates for a Gene Therapy Trial." HUMAN GENE THERAPY , vol.26, no.3, pp.145-152.

@article{article, author={Rita FERLA Et Al. }, title={Prevalence of Anti-Adeno-Associated Virus Serotype 8 Neutralizing Antibodies and Arylsulfatase B Cross-Reactive Immunologic Material in Mucopolysaccharidosis VI Patient Candidates for a Gene Therapy Trial}, journal={HUMAN GENE THERAPY}, year=2015, pages={145-152} }